Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

NCT06988618 · clinicaltrials.gov ↗
RECRUITING
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Galderma R&D